Andan, Carmen R.

HRN: 28 23 30  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2025
CEFTRIAXONE 1G (VIAL)
12/25/2025
12/31/2025
IV
2gm
OD
T/C CAP; T/C Complicated UTI
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines